Maier TJ - Search Results

1

Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity.

Kahnt AS, Rörsch F, Diehl O, Hofmann B, Lehmann C, Steinbrink SD, Angioni C, Geisslinger G, Grösch S, Steinhilber D, Maier TJ. Kahnt AS, et al. Among authors: maier tj. Biochem Pharmacol. 2013 Jul 15;86(2):286-96. doi: 10.1016/j.bcp.2013.05.005. Epub 2013 May 14. Biochem Pharmacol. 2013. PMID: 23684692

2

Activation of c-Jun-N-terminal-kinase is crucial for the induction of a cell cycle arrest in human colon carcinoma cells caused by flurbiprofen enantiomers.

Grösch S, Tegeder I, Schilling K, Maier TJ, Niederberger E, Geisslinger G. Grösch S, et al. Among authors: maier tj. FASEB J. 2003 Jul;17(10):1316-8. doi: 10.1096/fj.02-0919fje. Epub 2003 May 20. FASEB J. 2003. PMID: 12759338

3

Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.

Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S. Maier TJ, et al. Biochem Pharmacol. 2004 Apr 15;67(8):1469-78. doi: 10.1016/j.bcp.2003.12.014. Biochem Pharmacol. 2004. PMID: 15041464

4

Induction of apoptosis by R-flurbiprofen in human colon carcinoma cells: involvement of p53.

Grösch S, Schilling K, Janssen A, Maier TJ, Niederberger E, Geisslinger G. Grösch S, et al. Among authors: maier tj. Biochem Pharmacol. 2005 Mar 1;69(5):831-9. doi: 10.1016/j.bcp.2004.11.026. Epub 2005 Jan 13. Biochem Pharmacol. 2005. PMID: 15710360

5

Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.

Maier TJ, Janssen A, Schmidt R, Geisslinger G, Grösch S. Maier TJ, et al. FASEB J. 2005 Aug;19(10):1353-5. doi: 10.1096/fj.04-3274fje. Epub 2005 Jun 9. FASEB J. 2005. PMID: 15946992

6

Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment.

Janssen A, Maier TJ, Schiffmann S, Coste O, Seegel M, Geisslinger G, Grösch S. Janssen A, et al. Among authors: maier tj. Eur J Pharmacol. 2006 Jul 1;540(1-3):24-33. doi: 10.1016/j.ejphar.2006.04.030. Epub 2006 May 3. Eur J Pharmacol. 2006. PMID: 16730702

7

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.

Grösch S, Maier TJ, Schiffmann S, Geisslinger G. Grösch S, et al. Among authors: maier tj. J Natl Cancer Inst. 2006 Jun 7;98(11):736-47. doi: 10.1093/jnci/djj206. J Natl Cancer Inst. 2006. PMID: 16757698 Review.

8

Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition.

Brenneis C, Maier TJ, Schmidt R, Hofacker A, Zulauf L, Jakobsson PJ, Scholich K, Geisslinger G. Brenneis C, et al. Among authors: maier tj. FASEB J. 2006 Jul;20(9):1352-60. doi: 10.1096/fj.05-5346com. FASEB J. 2006. PMID: 16816110

9

p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells.

Janssen A, Schiffmann S, Birod K, Maier TJ, Wobst I, Geisslinger G, Grösch S. Janssen A, et al. Among authors: maier tj. Biochem Biophys Res Commun. 2008 Jan 25;365(4):698-703. doi: 10.1016/j.bbrc.2007.11.051. Epub 2007 Nov 26. Biochem Biophys Res Commun. 2008. PMID: 18036557

10

Dimethylcelecoxib inhibits prostaglandin E2 production.

Wobst I, Schiffmann S, Birod K, Maier TJ, Schmidt R, Angioni C, Geisslinger G, Grösch S. Wobst I, et al. Among authors: maier tj. Biochem Pharmacol. 2008 Jul 1;76(1):62-9. doi: 10.1016/j.bcp.2008.04.008. Epub 2008 Apr 24. Biochem Pharmacol. 2008. PMID: 18508034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page